Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Amount Raised
$1.6 Million
Round Type
Post-IPO Equity
DallasBiotechnologyDescription
On September 28, 2026, Lantern Pharma Inc. entered into a securities purchase agreement with an institutional investor, agreeing to issue shares and warrants in a registered direct offering. The closing of this offering occurred on September 30, 2026. This funding will support the company's ongoing efforts in developing cancer therapies
Fundz sees it the moment Lantern Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Lantern Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.